LACTB suppresses carcinogenesis in lung cancer and regulates the EMT pathway

Lung cancer causes thousands of deaths worldwide every year, and present therapeutics show little benefit for advanced-stage patients. Researchers do not know why and how lung cancer begins. Lactamase β (LACTB) is a tumor-suppressor in some cancers. However, its role in lung cancer is unknown. By an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yihui, Shi, Hubo, Wang, Min, Huang, Ping, Xu, Mingjie, Han, Shuyi, Li, Huanjie, Wang, Yunshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815028/
https://www.ncbi.nlm.nih.gov/pubmed/35222724
http://dx.doi.org/10.3892/etm.2022.11172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815028/
https://www.ncbi.nlm.nih.gov/pubmed/35222724
http://dx.doi.org/10.3892/etm.2022.11172

Ejemplares similares